HemaVision is a French DeepTech biotechnology company developing an AI-powered 3D cell imaging platform for advanced cell characterization and quality control. By combining proprietary cell labeling, volumetric imaging, and machine learning, HemaVision provides rapid, non-destructive insights into cellular state and phenotype for research, bioproduction, and future diagnostic applications.
